Group Conclusions

1
Group Conclusions

• CILINICAL ASPECTS
• Spanish Group
• Brasil,Chile,Colombia,Ecuador, Cuba,Honduras,
  Panama, Paraguay, Peru, El Salvador, Mexico,
  Haiti

2
Aspects with enough illustration
Case Definition There is clarity and precision in the influenza H5N1 definition found in the evidence
Clinical Chart The available information to be present at cases allows to clearly identify the level of required complexity to attend (severity of the clinical symptoms) of the influenza H5N1
Clinical Signs in Children Clinical signs and differential diagnosis with other respiratory pathologies and the therapeutically handling in children of different age have been determined
3
Aspects with enough illustration
Clinical Chart in Adults Clinical signs and differential diagnosis with other respiratory pathologies and the therapeutically handling in adults have been determined, according to the risks conditions.
Diagnosis Support The defined diagnosis test are clear and give enough information for the available diagnosis
Samples Transportation and Handling. There is clarity about samples and specimens collection, conservation, and transportation for diagnosis. To include process and final disposition.
4
Aspects requiring adjustments
To include the AIEPI as a screen for primary levels
To include in the differential diagnosis the Hantavirus
To define the utility of fast tests having been used in the stational influenza for the pandemic or otherwise to investigate which must be used
To develop strategies for the existing regulations in laboratory implementation
To identify if there are experiences with antiviral prophylaxis in people having contact with infected poultry
To evaluate the practices been used by the Infection Committee en each one of the countries
5
Requirements to be developed by WHO/PAHO through
experts network
Lab network organization strategies and flow for samples processing.
To identify new antiviral that may be used in the treatment To evaluate combined therapies between antiviral and other drugs as the corticosteroids
To investigate antiviral resistance and the crossed reactions with other drugs profile of drug sensitivity
To develop strategies to put in practice protection measures to the visitors and family and that one referred on as home care To improve strategies for handle residues and corps
6
Requirements to be developed by WHO/PAHO
through experts network
To include within the reports given by PAHO the outbreaks situation worldwide the following information symptoms by age group (less than 6 months 6 months to 2 years 2-15 years 15-64 and more than 65.
Consolidation of the existing studies in the world about the efficacy of the antiviral treatment. Strategys definition of the business strategies to acquire drugs at low price.
To define methodologies to evaluate the prophylaxis efficacy with each type of antiviral To consolidate all the existing studies about the prophylaxis efficacy
Samples Transportation and Handling. There is clarity about samples and specimens collection, conservation, and transportation for diagnosis. To include process and final disposition
7
New lines to include
Etical Aspects
Legal Aspects
Information and Communication